Table 3.
Association between IMDC outcomes and CRP levels before and after treatment
Characteristic | N | Initial CRP Median (IQR) |
p value | N | Post-treatment CRP Median (IQR) |
p value |
---|---|---|---|---|---|---|
Clinical remission | 0.146 | 0.680 | ||||
Yes | 54 | 27.5 (9.4-59.5) | 84 | 3.5 (1.2-13.5) | ||
No | 15 | 14.5 (7.8-32.3) | 18 | 4.1 (1.0-10.7) | ||
Endoscopic remission | 0.884 | 0.063 | ||||
Yes | 18 | 20.7 (8.6-59.5) | 32 | 2.2 (0.6-7.2) | ||
No | 12 | 20.0 (8.7-49.3) | 23 | 4.0 (2.0-10.3) | ||
Histologic remission | 0.613 | 0.143 | ||||
Yes | 14 | 18.1 (12.1-40.0) | 24 | 2.0 (0.6-6.2) | ||
No | 18 | 27.8 (8.6-69.0) | 33 | 3.8 (1.9-9.1) | ||
Symptom recurrence | 0.310 | 0.512 | ||||
Yes | 18 | 27.5 (15.2-55.4) | 29 | 3.8(1.6-17.5) | ||
No | 52 | 17.9 (7.4-45.8) | 72 | 3.5(1.0-10.9) |
Footnote: Mann-Whitney U test was used and reported as median and IQR.